Free Trial

5 Stocks with Unusually Large Short Interest

Short Squeeze Stock Market Share Prices Increase Sell Make Money 3d Illustration

Key Points

  • With the market soaring to new heights, fueled by tech, high short-interest stocks are again under the spotlight.
  • ABR, a real estate investment trust, maintains positive sentiment despite a 36.8% short interest as of February 15, with analysts forecasting a 22% upside potential.
  • CVNA and UPST both face significant short interest, with CVNA having 16.51% short interest and UPST having 35.64% as of February 15.
  • 5 stocks we like better than Upstart

With the broader market reaching new all-time highs, primarily driven by the tech sector and specifically semiconductor stocks fueled by the hype surrounding AI, the spotlight is once again beginning to shine on high short-interest stocks

These companies, facing elevated levels of short interest, have been subject to intense scrutiny and volatility as investors and short sellers engage in a tug-of-war over their stock prices. So, with investor confidence and speculation significantly on the rise, let’s delve into five of the highest-shorted stocks currently in the market and why it may be time to learn how to short stocks

Upstart Holdings NASDAQ: UPST

Upstart is a lending platform in the United States that employs AI technology to make credit decisions. It offers loans for various purposes, and leverages advanced algorithms to assess creditworthiness beyond traditional factors.

The overwhelming bearish sentiment appears aligned with the market on UPST, as the stock has fallen over 35% year-to-date and almost 20% over the last month. UPST is one of the lowest-rated stocks, with a reduce rating based on nine analyst ratings. The short interest has remained severely elevated despite a significant selloff in recent months. As of February 15, 35.64% of the float was sold short, equalling almost 26 million shares positioned short. Should momentum shift to the upside, the considerable short interest might exacerbate the move.

Carvana NYSE: CVNA

Carvana is an online platform primarily operating in the United States that is focused on automotive retail. The company facilitates buying, selling, and financing vehicles through its website, offering customers a simplified and digital car purchasing experience.

Thanks to its elevated short interest and recent earnings, the online automotive retailer's stock has posted impressive gains recently. Year-to-date shares are up 46% and a whopping 770% over the previous year. The sentiment surrounding CVNA is also overwhelmingly bearish, with recent insider selling, a consensus rating of reduce, and a price target forecasting a 43% downside. As of February 15, the short interest in the stock was 16.51% or 33.3 million shares positioned short. NYSE: AI focuses on enterprise AI software solutions. Its offerings span predictive maintenance, fraud detection, and supply chain optimization and cater to various industries.

Analysts are not as bearish on the name as on the above two, with a consensus analyst rating of hold based on ten analyst ratings. However, the bearish sentiment is present, with insiders selling stock during the previous quarter, a heightened short interest, and the name featuring on the lowest-rated stocks list. As of February 15, 28.81% of the float in AI was sold short, totaling 34.5 million shares. 

Arbor Realty Trust NYSE: ABR

Arbor Realty is a real estate investment trust headquartered in Uniondale, New York. Led by Chairman and CEO Ivan Kaufman, the company invests in diverse structured finance assets within the U.S. real estate market. Focusing on multifamily, single-family rental, and commercial real estate sectors, Arbor manages a portfolio exceeding $42 billion and originates over $16 billion in loans annually.

Unlike the above stocks, ABR has positive sentiment despite highly high short interest. The consensus analyst rating for ABR is hold, and the consensus price target is $15.67, which sees almost 22% upside for the stock. However, as of February 15, the short interest was up 8.56% over the previous month to 36.8%, making ABR one of the highest shorted stocks. As of February 15, 69.3 million shares were sold short.

ImmunityBio NYSE: IBRX

ImmunityBio, Inc. is a clinical-stage biotechnology company dedicated to advancing therapies and vaccines to bolster the immune system against cancer and infectious diseases. The company strives to enhance patient outcomes through innovative immunotherapy and cell therapy platforms by fostering robust and sustained immune responses.

IBRX, like ABR, is one of the highest-shorted stocks on the NYSE, with a 36.07% short float as of February 15. Over the prior month, that figure increased by 7.31%, with the total number of shares sold short now at a staggering 43.9 million. With only one analyst rating, the stock has a hold rating and a price target forecasting over 21% of downside. 

Should you invest $1,000 in Upstart right now?

Before you consider Upstart, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upstart wasn't on the list.

While Upstart currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Arbor Realty Trust (ABR)
3.01 of 5 stars
Carvana (CVNA)
2.7771 of 5 stars
$109.15-0.7%N/A47.87Hold$77.60 (AI)
3.0589 of 5 stars
ImmunityBio (IBRX)
0.1272 of 5 stars
Upstart (UPST)
3.5129 of 5 stars
Compare These Stocks  Add These Stocks to My Watchlist 

Ryan Hasson

About Ryan Hasson


Contributing Author

Technical Analysis, Momentum Trading, Risk Management


Ryan Hasson has been a contributing writer for MarketBeat since 2023.

Areas of Expertise

Equity research and analysis, technical analysis and price action, market sentiment and underlying themes, risk management and trading psychology


Bachelor of Commerce in Financial Management

Past Experience

Equities trader, Kershner Trading Group, business analysis consultant, SMB Capital

Zoom International: Business Analysis Consultant.

Featured Articles and Offers

Search Headlines: